Graham J Mann

Graham J Mann

UNVERIFIED PROFILE

Are you Graham J Mann?   Register this Author

Register author
Graham J Mann

Graham J Mann

Publications by authors named "Graham J Mann"

Are you Graham J Mann?   Register this Author

100Publications

4142Reads

16Profile Views

Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.

Appl Health Econ Health Policy 2019 Oct;17(5):669-681

NHMRC Clinical Trials Centre and Melanoma Institute Australia, The University of Sydney, Camperdown, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40258-019-00483-6DOI Listing
October 2019

Molecular Genomic Profiling of Melanocytic Nevi.

J Invest Dermatol 2019 Aug 14;139(8):1762-1768. Epub 2019 Feb 14.

Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X193011
Publisher Site
http://dx.doi.org/10.1016/j.jid.2018.12.033DOI Listing
August 2019

Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.

J Invest Dermatol 2019 Jun 27. Epub 2019 Jun 27.

Center for Translational Skin Research, The University of Sydney, Westmead, New South Wales, Australia; Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2019.06.128DOI Listing
June 2019

Tape Stripped Stratum Corneum Samples Prove to be Suitable for Comprehensive Proteomic Investigation of Actinic Keratosis.

Proteomics Clin Appl 2019 05 8;13(3):e1800084. Epub 2018 Oct 8.

Centre for Translational Skin Research, The University of Sydney, Westmead, New South Wales, 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201800084DOI Listing
May 2019

Sunscreen Use and Melanoma Risk Among Young Australian Adults.

JAMA Dermatol 2018 09;154(9):1001-1009

Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.1774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143037PMC
September 2018

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.

Br J Cancer 2018 09 17;119(6):713-723. Epub 2018 Aug 17.

Australian Proteome Analysis Facility (APAF), Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0227-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173697PMC
September 2018

Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis.

Int J Cancer 2018 08 5;143(3):508-514. Epub 2018 Mar 5.

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300, Herston road, Brisbane, QLD, 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31334DOI Listing
August 2018

A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma.

Proteomics Clin Appl 2018 05 19;12(3):e1700094. Epub 2018 Jan 19.

School of Life and Environmental Sciences, University of Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201700094DOI Listing
May 2018

A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia.

Appl Health Econ Health Policy 2018 04;16(2):235-242

Sydney School of Public Health, The University of Sydney, The Lifehouse, Level 6-North, 119-143 Missenden Road, Camperdown, NSW, 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40258-017-0368-0DOI Listing
April 2018

Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

JAMA Dermatol 2018 01;154(1):52-59

National Health and Medical Research Council (NHMRC) Clinical Trial Centre, The University of Sydney, Camperdown, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2017.4701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833574PMC
January 2018

Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia.

Australas J Dermatol 2017 Nov 1;58(4):278-285. Epub 2016 Aug 1.

Cancer Epidemiology and Prevention Research, Sydney School of Public Health, University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12530DOI Listing
November 2017

Mutation load in melanoma is affected by MC1R genotype.

Pigment Cell Melanoma Res 2017 03 7;30(2):255-258. Epub 2017 Mar 7.

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pcmr.12571
Publisher Site
http://dx.doi.org/10.1111/pcmr.12571DOI Listing
March 2017

Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Lab Invest 2017 02 9;97(2):130-145. Epub 2017 Jan 9.

Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2016.143DOI Listing
February 2017

Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study.

JAMA Dermatol 2017 01;153(1):23-29

Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia3Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2016.3327DOI Listing
January 2017

Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.

J Clin Oncol 2017 Jan 28;35(1):63-71. Epub 2016 Oct 28.

Caroline G. Watts, Sydney School of Public Health, The University of Sydney; Anne E. Cust, Sydney School of Public Health, The University of Sydney, and Melanoma Institute Australia, The University of Sydney; Graham J. Mann, Melanoma Institute Australia, The University of Sydney, and Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney; Rachael L. Morton, NHMRC Clinical Trials Centre, The University of Sydney, and Melanoma Institute Australia, The University of Sydney; and Scott W. Menzies, Discipline of Dermatology, University of Sydney, and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.4308DOI Listing
January 2017

Economic evaluations of psychosocial interventions in cancer: a systematic review.

Psychooncology 2016 12 26;25(12):1380-1392. Epub 2016 Jan 26.

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pon.4075
Publisher Site
http://dx.doi.org/10.1002/pon.4075DOI Listing
December 2016

"Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma.

Support Care Cancer 2016 12 27;24(12):4849-4859. Epub 2016 Jul 27.

Centre for Cancer Research, The University of Sydney at The Westmead Institute for Medical Research and Melanoma Institute Australia, Sydney, NSW, 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3339-3DOI Listing
December 2016

Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial.

J Clin Oncol 2016 12 28;34(36):4405-4414. Epub 2016 Oct 28.

Mbathio Dieng and Anne E. Cust, Sydney School of Public Health, The University of Sydney; Anne E. Cust, Rachael L. Morton, and Graham J. Mann, The Melanoma Institute Australia, The University of Sydney; Phyllis N. Butow and Stephanie Tesson, School of Psychology, The University of Sydney; Daniel S.J. Costa, Pain Management Research Institute, The University of Sydney; Rachael L. Morton, NHMRC Clinical Trials Centre, The University of Sydney; Scott W. Menzies, Sydney Medical School, The University of Sydney; Shab Mireskandari, Centre for Medical Psychology & Evidence-based Decision-making, The University of Sydney; Graham J. Mann, Westmead Institute for Medical Research, The University of Sydney; Scott W. Menzies, Royal Prince Alfred Hospital; Nadine A. Kasparian, School of Women's and Children's Health, UNSW Medicine, The University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2278DOI Listing
December 2016

PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.

Clin Cancer Res 2016 08 9;22(15):3915-23. Epub 2016 Mar 9.

Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1714DOI Listing
August 2016

Differential distribution improves gene selection stability and has competitive classification performance for patient survival.

Nucleic Acids Res 2016 07 17;44(13):e119. Epub 2016 May 17.

School of Mathematics and Statistics, University of Sydney, NSW 2006, Australia ARC Centre of Excellence for Mathematical & Statistical Frontiers, University of Melbourne, Parkville VIC 3010, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291264PMC
July 2016

Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.

Pathology 2016 Apr 9;48(3):261-6. Epub 2016 Mar 9.

Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.01.001DOI Listing
April 2016

The molecular profile of metastatic melanoma in Australia.

Pathology 2016 Feb 18;48(2):188-93. Epub 2016 Jan 18.

Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2015.12.008DOI Listing
February 2016

Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.

J Invest Dermatol 2016 Jan;136(1):245-254

School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/JID.2015.355DOI Listing
January 2016

Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.

Health Expect 2015 Dec 10;18(6):3123-35. Epub 2014 Nov 10.

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hex.12301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810691PMC
December 2015

Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.

Pathology 2015 Dec;47(7):683-93

1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000324DOI Listing
December 2015

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.

Nat Genet 2015 Sep 3;47(9):987-995. Epub 2015 Aug 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557485PMC
September 2015

The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease.

BMC Psychol 2015 11;3(1):23. Epub 2015 Jul 11.

Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, The Lifehouse, Level 6 North, 119-143 Missenden Road, Camperdown, NSW 2050 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40359-015-0074-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499167PMC
July 2015

ClassifyR: an R package for performance assessment of classification with applications to transcriptomics.

Bioinformatics 2015 Jun 1;31(11):1851-3. Epub 2015 Feb 1.

School of Mathematics and Statistics, University of Sydney, New South Wales, Australia and Melanoma Institute Australia, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btv066DOI Listing
June 2015

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

Pigment Cell Melanoma Res 2015 May 5;28(3):254-66. Epub 2015 Jan 5.

Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12343DOI Listing
May 2015

Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults.

Cancer Epidemiol Biomarkers Prev 2015 Apr 27;24(4):736-43. Epub 2015 Jan 27.

Centre for Cancer Research, University of Sydney at Westmead Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-1203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698346PMC
April 2015

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.

Hered Cancer Clin Pract 2014 20;12(1):20. Epub 2014 Nov 20.

Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-12-20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361137PMC
March 2015

Histologic features of melanoma associated with CDKN2A genotype.

J Am Acad Dermatol 2015 Mar 13;72(3):496-507.e7. Epub 2015 Jan 13.

Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.11.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333073PMC
March 2015

Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.

Int J Cancer 2015 Feb 24;136(4):863-74. Epub 2014 Jul 24.

School of Mathematics & Statistics, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29047DOI Listing
February 2015

Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.

JAMA Dermatol 2015 Feb;151(2):178-86

Sydney School of Public Health, University of Sydney, Sydney, Australia7Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2014.1952DOI Listing
February 2015

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

J Natl Cancer Inst 2015 Feb 13;107(2). Epub 2014 Dec 13.

Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH); Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA); Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG); Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB); Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB); Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO); Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ); Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG); Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ); Translational Genomics Institute, Phoenix, AZ (JMT); University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM); Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334787PMC
February 2015

The effect on melanoma risk of genes previously associated with telomere length.

J Natl Cancer Inst 2014 Oct 17;106(10). Epub 2014 Sep 17.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK (MMI, DTB, JCT, MHa, JRM, JANB, JHB); Oncogenomics (NKH), Genetic Epidemiology (NGM), Inflammatory Bowel Diseases Laboratory (GLRS), Cancer Control Group (DCW), Statistical Genetics (SM, MHL), and Molecular Epidemiology (GWM), QIMR Berghofer Medical Research Institute, Brisbane, Australia; INSERM, UMR-946, Genetic Variation and Human Diseases Unit, Paris, France (MB, FD); Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France (MB, FD); Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Australia (AEC); Department of Oncology, University of Cambridge, Cambridge, UK (AMD, PDPP); Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (JEL); Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia (EKM, SVW); Centre for Cancer Biomarkers CCBIO (LAA) and Gade Laboratory for Pathology (AM), Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway (LAA); Department of Pathology, Molecular Pathology (PAA) and Department of Dermatology (PH), Oslo University Hospital, Rikshospitalet, Oslo, Norway; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France (MFA); Department of Dermatology (EA) and Oncogenics Unit (EA, EF), Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel (EA); Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy (GBS, EFPG); Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital, Genoa, Italy (GBS, EFPG); Division of Cancer Epidemiology and Gene

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/IlesMM_JNCI_EPUB
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju267
Publisher Site
http://dx.doi.org/10.1093/jnci/dju267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196080PMC
October 2014

Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Carcinogenesis 2014 Sep 30;35(9):2097-101. Epub 2014 Jun 30.

Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146422PMC
September 2014

Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.

JAMA Dermatol 2014 Aug;150(8):819-27

Discipline of Dermatology, University of Sydney at the Sydney Cancer Centre, Sydney, New South Wales, Australia2Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2014.514DOI Listing
August 2014

Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer.

Psychooncology 2014 Jun 14;23(6):613-25. Epub 2014 Jan 14.

Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3476DOI Listing
June 2014

Molecular biomarkers of prognosis in melanoma: how far are we from the clinic?

Melanoma Res 2013 Dec;23(6):423-5

aThe University of Sydney at Westmead Millennium Institute for Medical Research bMelanoma Institute Australia, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000001DOI Listing
December 2013

Molecular interaction networks for the analysis of human disease: utility, limitations, and considerations.

Proteomics 2013 Dec;13(23-24):3393-405

Sydney Medical School, Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201200570DOI Listing
December 2013

VAN: an R package for identifying biologically perturbed networks via differential variability analysis.

BMC Res Notes 2013 Oct 25;6:430. Epub 2013 Oct 25.

School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-6-430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015612PMC
October 2013

Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.

Pigment Cell Melanoma Res 2013 Sep 5;26(5):708-22. Epub 2013 Jul 5.

Sydney Medical School, The University of Sydney at Westmead Millennium Institute for Medical Research, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12126DOI Listing
September 2013

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients.

Oncoimmunology 2013 Sep 3;2(9):e25564. Epub 2013 Jul 3.

Melanoma Institute Australia; North Sydney, NSW Australia ; The University of Sydney; Sydney, NSW Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820811PMC
September 2013

Psycho-educational interventions for melanoma survivors: a systematic review.

Psychooncology 2013 Jul 30;22(7):1444-56. Epub 2012 Aug 30.

School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pon.3165
Publisher Site
http://dx.doi.org/10.1002/pon.3165DOI Listing
July 2013

A variant in FTO shows association with melanoma risk not due to BMI.

Nat Genet 2013 Apr 3;45(4):428-32, 432e1. Epub 2013 Mar 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St. James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/Iles_etal_Nature
Web Search
http://www.nature.com/doifinder/10.1038/ng.2571
Publisher Site
http://dx.doi.org/10.1038/ng.2571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640814PMC
April 2013

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.

Mol Cancer Ther 2012 Apr 1;11(4):888-97. Epub 2012 Mar 1.

Queensland Institute of Medical Research, Oncogenomics Laboratory, Queensland University of Technology, Brisbane, Queensland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0676DOI Listing
April 2012

Review and cross-validation of gene expression signatures and melanoma prognosis.

J Invest Dermatol 2012 Feb 29;132(2):274-83. Epub 2011 Sep 29.

Sydney Medical School, The University of Sydney at Westmead Millennium Institute, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2011.305DOI Listing
February 2012

Genome-wide association study identifies three new melanoma susceptibility loci.

Nat Genet 2011 Oct 9;43(11):1108-13. Epub 2011 Oct 9.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St James’s University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251256PMC
October 2011

Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies.

Mol Cancer Ther 2011 Aug 9;10(8):1520-8. Epub 2011 Jun 9.

Melanoma Genomics and Genetic Epidemiology Research Group, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0901DOI Listing
August 2011